Sulfasalazine Improves Insulin Resistance and Endothelial Dysfunction in Metabolic Syndrome Patients
Kanchan Vohra, Pawan Krishan, Sudhir Varma & Harpreet Singh Kalra · Journal of Advances in Medicine and Medical Research · 2015
Aim: Metabolic syndrome (MetS) and all its components are independently characterized by the presence of low-grade chronic inflammation. The study aimed at controlling inflammation using sulfasalazine 500mg, once a day treatment in comparison to placebo in MetS patients. Study De...